Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease
Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease - The DREAMS-PD Study
The Cleveland Clinic
10 participants
Nov 22, 2025
INTERVENTIONAL
Conditions
Summary
This study employs an exploratory, prospective, single center, naturalistic clinical trial design with a randomized crossover intervention.
Eligibility
Inclusion Criteria7
- Male or female \> 18 years of age
- Diagnosed with idiopathic Parkinson Disease
- Have bilateral implantation of Medtronic's PerceptTM PC (Medtronic Neurological Division, Minneapolis, MN, USA) Deep Brain Stimulation (DBS) system targeting the subthalamic nucleus (STN) and have had their stimulation settings optimized for a minimum of three months
- Report a response score of one or greater on question 1.7 of the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part I;
- Demonstrate ability to ambulate independently;
- Be capable of providing informed consent;
- If taking sleep-supporting medications, dosing must be stable for at least 30 days
Exclusion Criteria5
- Presence of neurological diseases other than Parkinson Disease, such as stroke or multiple sclerosis
- Active sleep disorders, including narcolepsy, moderate to severe (Apnea-Hypopnea Index\>=15) untreated sleep apnea, uncontrolled restless legs syndrome
- Cognitive impairment meeting the criteria for dementia as per the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), based on formal neuropsychological evaluation
- Ongoing alcohol or substance abuse; Working night shifts or irregular work hours
- The main concern for vulnerable subjects will be for the possibility of reduced decision-making capacity. For this we intend to exclude individuals who have a diagnosis of dementia.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will undergo three different nighttime-only Deep Brain Stimulation (DBS) settings in a randomized crossover design: 0% amplitude (stimulation off), 50% amplitude of their optimal clinical DBS settings, and full clinical DBS settings (100%). Each setting is applied for two weeks during sleep, over a total six-week home monitoring period. The intervention is designed to assess how varying levels of subthalamic nucleus DBS influence sleep quality and neural oscillatory activity. Only nighttime DBS settings are modified; daytime settings remain unchanged.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07110376